Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention

被引:17
|
作者
Zhou, You [1 ]
Chen, Zhangwei [1 ]
Ma, Jiaqi [1 ]
Chen, Ao [1 ]
Lu, Danbo [1 ]
Wu, Yuan [1 ]
Ren, Daoyuan [1 ]
Zhang, Chi [1 ]
Dai, Chunfeng [1 ]
Zhang, Yaqi [1 ]
Qian, Juying [1 ]
Ge, Junbo [1 ]
机构
[1] Fudan Univ, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Dept Cardiol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Periprocedural myocardial injury; Percutaneous coronary intervention; Cardiac troponin T; CREATINE KINASE-MB; CARDIAC TROPONIN-T; PROGNOSTIC VALUE; MICROEMBOLIZATION; INFARCTION; MYONECROSIS; ELEVATION; DIAGNOSIS; IMPACT; DAMAGE;
D O I
10.1016/j.jjcc.2020.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although technological and equipment innovations have given rise to delicate and safe coronary intervention procedures, periprocedural myocardial injury (PMI) is still one of the common complications. The relationship between PMI, defined by various biomarker thresholds, and clinical prognosis remains controversial. We sought to assess the determinants and prognosis of PMI in patients with stable coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI). Methods: Consecutive stable CAD patients with negative preoperative troponin T levels undergoing elective PCI in our hospital were enrolled from July 2017 to December 2017. PMI was defined as troponin T values >99th percentile upper reference limit (URL) within 16-24 h post-PCI. The correlation of cardiovascular events and PMI was assessed after a median follow-up of 18 months. Results: PMI occurred in 45.3% of the 1572 patients included, with 11.2% having troponin T levels elevated more than 5 times the URL after PCI. Independent risk factors for PMI were age >= 65 years, prior PCI, bifurcation lesion, stent number, and multivessel disease. During the follow-up period, patients with PMI had a higher incidence of unplanned revascularization [10.8% vs. 7.2%, adjusted hazard ratio (adHR) 1.40, 95% confidence interval (CI) 1.04-2.06; p = 0.045] and target vessel revascularization (5.8% vs. 2.7%, adHR 1.90, 95% CI 1.06-3.38; p = 0.030) than those without PMI. However, no significant impact of PMI on the risk of death and myocardial infarction was found. Conclusions: PMI defined by troponin T levels >99th percentile URL correlated with an increased risk of cardiovascular events in stable CAD patients undergoing elective PCI. (C) 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [41] Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention
    Piccolo, Raffaele
    Leone, Attilio
    Simonetti, Fiorenzo
    Avvedimento, Marisa
    Angellotti, Domenico
    Manzi, Lina
    Verde, Nicola
    Spaccarotella, Carmen Anna Maria
    Di Serafino, Luigi
    Cirillo, Plinio
    Gargiulo, Giuseppe
    Fortunato, Giuliana
    Franzone, Anna
    Esposito, Giovanni
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2023, 102 (02) : 212 - 220
  • [42] Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention
    Verdoia, Monica
    Schaffer, Alon
    Barbieri, Lucia
    Di Giovine, Gabriella
    Marino, Paolo
    De Luca, Giuseppe
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (04) : 297 - 304
  • [43] Long-term clinical outcome of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention for chronic total occlusion lesions
    Tanaka, H.
    Habara, S.
    Fuku, Y.
    Goto, T.
    Kadota, K.
    Mitsudo, K.
    EUROPEAN HEART JOURNAL, 2015, 36 : 645 - 645
  • [44] Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention
    Buturak, Ali
    Degirmencioglu, Aleks
    Erturk, Mehmet
    Karakurt, Huseyin
    Demir, Ali Riza
    Surgit, Ozgur
    Pusuroglu, Hamdi
    Akgul, Ozgur
    Serteser, Mustafa
    Norgaz, Tugrul
    Gorgulu, Sevket
    CORONARY ARTERY DISEASE, 2015, 26 (04) : 333 - 340
  • [45] Elective Percutaneous Coronary Intervention The Relationship between Preprocedural Blood Glucose Levels and Periprocedural Myocardial Injury
    Madani, Mohsen
    Alizadeh, Keivan
    Ghazaee, Sepideh Parchami
    Zavarehee, Abbas
    Abdi, Seifollah
    Shakerian, Farshad
    Salehi, Negar
    Firouzi, Ata
    TEXAS HEART INSTITUTE JOURNAL, 2013, 40 (04): : 410 - 417
  • [46] The index of microvascular resistance identifies patients with periprocedural myocardial infarction in elective percutaneous coronary intervention
    Layland, Jamie J.
    Whitbourn, Robert J.
    Burns, Andrew T.
    Somaratne, Jithendra
    Leitl, Georg
    MacIsaac, Andrew I.
    Wilson, Andrew
    HEART, 2012, 98 (20) : 1492 - 1497
  • [47] The randomized clinical trial of coenzyme Q10 for the prevention of periprocedural myocardial injury following elective percutaneous coronary intervention
    Aslanabadi, Naser
    Safaie, Naser
    Asgharzadeh, Yousef
    Houshmand, Fatemeh
    Ghaffari, Samad
    Garjani, Alireza
    Dousti, Samaneh
    Hamishehkar, Hadi
    Entezari-Maleki, Taher
    CARDIOVASCULAR THERAPEUTICS, 2016, 34 (04) : 254 - 260
  • [48] Effect Of Trimetazidine Before Elective Percutaneous Coronary Intervention On Periprocedural Myocardial Damage
    Wang, Zhi Jian
    Zhou, Yu Jie
    Liu, Yu Yang
    Yu, Miao
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 192I - 192I
  • [49] Frequency and outcomes of periprocedural myocardial infarction in patients with chronic coronary syndromes undergoing percutaneous coronary intervention
    Ueki, Yasushi
    Raber, Lorenz
    CURRENT OPINION IN CARDIOLOGY, 2022, 37 (06) : 488 - 494
  • [50] Selective coronary angiography, percutaneous coronary intervention and asymptomatic periprocedural myocardial injury
    Griva, M.
    Stastny, J.
    Kopriva, P.
    Slabak, M.
    Coufal, Z.
    Strelec, J.
    Jarkovsky, J.
    Kojecky, V.
    Taborsky, M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1283 - 1283